GSDMA and obstructive sleep apnea syndrome: Given that current research suggests that GSDMD-mediated pyroptosis is a major promoter of OSA-related diseases, targeting the inhibition of GSDMD may help avoid the negative effects associated with inhibiting other gasdermin proteins, while still preserving GSDMD’s normal physiological functions.